|
Univariate and multivariate factors associated with undetectable viral load (n = 88) |
||||||
| Variable |
Unadjusted OR |
95%CI |
p-value |
Adjusted OR |
95%CI |
p-value |
|
|
||||||
| Female gender |
0.91 |
0.36 – 2.35 |
0.86 |
† |
||
| Age at treatment start (months) |
1.00 |
0.99 – 1.01 |
0.81 |
† |
||
| WHO stage 2&3 (vs WHO stage 4) |
2.80 |
1.07 – 7.35 |
0.04 |
* |
||
| Weight-for-age z-score |
1.29 |
0.94 – 1.77 |
0.12 |
* |
||
| Height-for-age z-score |
1.07 |
0.74 – 1.54 |
0.71 |
* |
||
| Weight-for-height z-score |
1.94 |
1.27 – 2.96 |
0.002 |
1.8 |
1.15 – 2.80 |
0.01 |
| CD4 percent |
1.04 |
0.97 – 1.12 |
0.27 |
* |
||
| CD4 absolute (cells/l) |
1.44 |
0.54 – 3.84 |
0.47 |
* |
||
| Log viral load |
0.87 |
0.48 – 1.60 |
0.66 |
* |
||
| Ritonavir-containing regimen |
0.33 |
0.13 – 0.87 |
0.03 |
† |
||
| Annual average MR adherence ≥ 90% |
10.30 |
1.92 – 55.67 |
0.005 |
5.48 |
0.84 – 35.58 |
0.075 |
|
*Not included in building multivariate model †Not significantly associated with viral suppression after adjustment for weight-for-height z-score | ||||||
Davies et al. BMC Pediatrics 2008 8:34 doi:10.1186/1471-2431-8-34 |
||||||